Jie Xu (J Xu)

ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 29

Top Venues

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Leukemia

Oncogene

Signal transduction and targeted therapy

Fudan University

Vrije Universiteit Brussel (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fudan University Aug 01 2019

China

Professor/Group leader :: Institute of Biomedical Sciences

Shanghai Jiao Tong University School of Medicine Jan 01 2012 - Jul 31 2019

China

Principle Investigator, Professor :: Shanghai Institute of Digestive Diseases

Katholieke Universiteit Leuven Jul 01 2010 - Dec 31 2011

Belgium

Postdoc fellow

Education History

Vrije Universiteit Brussel Sep 01 2006 - Jun 15 2010

Belgium

PHD

Publications

Hong Fang, Hannah C Beird, Sa A Wang, Andrew F Ibrahim, Zhenya Tang, Guillin Tang, Mingjian James You, Shimin Hu, Jie Xu, Shaoying Li, C Cameron Yin, Siba El Hussein, Nhi Le, P Andrew Futreal, Carlos Bueso-Ramos, Beenu Thakral, Tapan Mahendra Kadia, Rebecca Thornton, Latasha Little, Curtis Gumbs, Xingzhi Song, L Jeffrey Medeiros, Wei Wang
T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis. Leukemia (2023)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37 (2) (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37 (2) (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37 (2) (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37 (2) (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia 37 (2) (2022)
Xiao-Bo Zheng, Jinen Song, Chune Yu, Zongguang Zhou, Xiaowei Liu, Jing Yu, Guangchao Xu, Jiqiao Yang, Xiujing He, Xin Bai, Ya Luo, Yu Bao, Huifang Li, Lie Yang, Mingqing Xu, Nan Song, Xiaodong Su, Jie Xu, Xuelei Ma, Hubing Shi
Single-cell transcriptomic profiling unravels the adenoma-initiation role of protein tyrosine kinases during colorectal tumorigenesis. Signal transduction and targeted therapy 7 (1) (2022)
Chushu Li, Hao Chi, Shouyan Deng, Huanbin Wang, Han Yao, Yungang Wang, Dawei Chen, Xun Guo, Jing-Yuan Fang, Fang He, Jie Xu
THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy. Journal for immunotherapy of cancer 9 (8) (2022)
Shaoying Li, Lianqun Qiu, Jie Xu, Pei Lin, Chi Young Ok, Guillin Tang, Timothy J McDonnell, Mingjian James You, Mahsa Khanlari, Roberto N Miranda, L Jeffrey Medeiros
High-grade B-cell lymphoma (HGBL)-NOS is clinicopathologically and genetically more similar to DLBCL/HGBL-DH than DLBCL. Leukemia (2022)
Mark G Evans, L Jeffrey Medeiros, Mario L Marques-Piubelli, Huan-You Wang, Carlos Ortiz-Hidalgo, Sergio Pina-Oviedo, Angela Morine, Mark W Clemens, Kelly K Hunt, Swaminathan Iyer, Qinglong Hu, Claudia Recavarren, Roberta Demichelis, Martha Romero, Aliyah R Sohani, Michael Misialek, Mitual B Amin, Carlos E Bueso-Ramos, Adrian A Carballo-Zarate, Hun J Lee, Chi Young Ok, Jie Xu, Roberto N Miranda
Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (12) (2021)
Yungang Wang, Shouyan Deng, Jie Xu
Proteasomal and lysosomal degradation for specific and durable suppression of immunotherapeutic targets. Cancer biology & medicine 17 (3) (2021)
L Jeffrey Medeiros, Mario L Marques-Piubelli, Valentina F I Sangiorgio, Roberto Ruiz-Cordero, Francisco Vega, Andrew L Feldman, Jennifer R Chapman, Mark W Clemens, Kelly K Hunt, Mark G Evans, Christine Khoo, Stephen Lade, Mark Silberman, Jerzy Morkowski, Edward M Pina, Daniel C Mills, Christopher M Bates, Winston B Magno, Aliyah R Sohani, Beth A Sieling, Joseph M O'Donoghue, Chris M Bacon, Neill Patani, Despina Televantou, Suzanne D Turner, Laura Johnson, Fiona MacNeill, Andrew C Wotherspoon, Swaminathan P Iyer, Luis E Malpica, Keyur Pravinchandra Patel, Jie Xu, Roberto N Miranda
Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (12) (2021)
Mahsa Khanlari, L Jeffrey Medeiros, Pei Lin, Jie Xu, M James You, Guilin Tang, Cheng Cameron Yin, Wei Wang, Lianqun Qiu, Roberto N Miranda, Carlos E Bueso-Ramos, Shaoying Li
Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (2021)
Mahsa Khanlari, Shaoying Li, Roberto N Miranda, Swaminathan Iyer, Sergej Konoplev, Pei Lin, Cheng Cameron Yin, Guilin Tang, Lianqun Qiu, Francisco Vega, L Jeffrey Medeiros, Jie Xu
Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T-cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc (2021)
Han Yao, Chushu Li, Fang He, Teng Song, Jean-Philippe Brosseau, Huanbin Wang, Hao-Jie Lu, Caiyun Fang, Hubing Shi, Jiang Lan, Jing-Yuan Fang, Jie Xu
A peptidic inhibitor for PD-1 palmitoylation targets its expression and functions. RSC chemical biology 2 (1) (2020)
Jie Xu, Jean-Philippe Brosseau, Hubing Shi
Targeted degradation of immune checkpoint proteins: emerging strategies for cancer immunotherapy. Oncogene 39 (48) (2020)
Suyang Hao, Xinyan Lu, Zimu Gong, Roland L Bassett, Shimin Hu, Sergej N Konoplev, Guilin Tang, Shaoying Li, Jie Xu, Mahsa Khanlari, Hans C Lee, Elisabet E Manasanch, Donna M Weber, Robert Z Orlowski, L Jeffrey Medeiros, Pei Lin
The survival impact of CKS1B gains or amplification is dependent on the background karyotype and TP53 deletion status in patients with myeloma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 34 (2) (2020)
Wei Xie, Jie Xu, Shimin Hu, Shaoying Li, Wei Wang, C Cameron Yin, Gokce Toruner, Zhenya Tang, L Jeffrey Medeiros, Guilin Tang
iAMP21 in acute myeloid leukemia is associated with complex karyotype, TP53 mutation and dismal outcome. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 33 (7) (2020)
Chushu Li, Han Yao, Huanbin Wang, Jing-Yuan Fang, Jie Xu
Repurposing screen identifies Amlodipine as an inducer of PD-L1 degradation and antitumor immunity. Oncogene 40 (6) (2020)
Jie Xu, Shaoying Li, L Jeffrey Medeiros
Reply to "PD-L1 expression in anaplastic large cell lymphoma". Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 33 (6) (2020)
Sofia Garces, C Cameron Yin, Roberto N Miranda, Keyur P Patel, Shaoying Li, Jie Xu, Beenu Thakral, Robert J Poppiti, Ana Maria Medina, Vathany Sriganeshan, Amilcar Castellano-Sánchez, Joseph D Khoury, Juan Carlos Garces, L Jeffrey Medeiros
Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an update. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 33 (6) (2020)
Jing Shen, Shaoying Li, L Jeffrey Medeiros, Pei Lin, Sa A Wang, Guilin Tang, C Cameron Yin, M James You, Joseph D Khoury, Swaminathan P Iyer, Roberto N Miranda, Jie Xu
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 33 (3) (2019)
Han Yao, Jiang Lan, Chushu Li, Hubing Shi, Jean-Philippe Brosseau, Huanbin Wang, Haojie Lu, Caiyun Fang, Yao Zhang, Lunxi Liang, Xiaolin Zhou, Chaojun Wang, Yu Xue, Yun Cui, Jie Xu
Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours. Nature biomedical engineering 3 (4) (2019)
Huanbin Wang, Han Yao, Chushu Li, Hubing Shi, Jiang Lan, Zhaoli Li, Yao Zhang, Lunxi Liang, Jing-Yuan Fang, Jie Xu
HIP1R targets PD-L1 to lysosomal degradation to alter T cell-mediated cytotoxicity. Nature chemical biology 15 (1) (2018)
Huan Bin Wang, Han Yao, Chu Shu Li, Lun Xi Liang, Yao Zhang, Ying Xuan Chen, Jing-Yuan Fang, Jie Xu
Rise of PD-L1 expression during metastasis of colorectal cancer: Implications for immunotherapy. Journal of digestive diseases 18 (10) (2018)
Sofia Garces, C Cameron Yin, Keyur P Patel, Joseph D Khoury, John T Manning, Shaoying Li, Jie Xu, Sergio Pina-Oviedo, Malisha R Johnson, Sergio González, Montserrat Molgó, Roberto Ruiz-Cordero, L Jeffrey Medeiros
Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 32 (1) (2018)
Y Zhang, Y Hu, J-L Wang, H Yao, H Wang, L Liang, C Li, H Shi, Y Chen, J-Y Fang, Jie Xu
Proteomic identification of ERP29 as a key chemoresistant factor activated by the aggregating p53 mutant Arg282Trp. Oncogene 36 (39) (2017)
Jin Qian, Yueyuan Li, Han Yao, Haiying Tian, Huanbin Wang, Luoyan Ai, Yuanhong Xie, Yujie Bao, Lunxi Liang, Ye Hu, Yao Zhang, Jilin Wang, Chushu Li, Jiayin Tang, Yingxuan Chen, Jie Xu, Jing-Yuan Fang
ASAP3 regulates microvilli structure in parietal cells and presents intervention target for gastric acidity. Signal transduction and targeted therapy 2 (2017)

Jie Xu.css-eqlu8i{font-size:small;padding-left:4px;} (J Xu)

Publication Activity (10 Years)

Top Topics

Top Venues

Jie Xu (J Xu)